| __timestamp | Dr. Reddy's Laboratories Limited | Novartis AG |
|---|---|---|
| Wednesday, January 1, 2014 | 56369000000 | 17345000000 |
| Thursday, January 1, 2015 | 62786000000 | 17404000000 |
| Friday, January 1, 2016 | 62427000000 | 17520000000 |
| Sunday, January 1, 2017 | 62453000000 | 17175000000 |
| Monday, January 1, 2018 | 65724000000 | 18407000000 |
| Tuesday, January 1, 2019 | 70421000000 | 14425000000 |
| Wednesday, January 1, 2020 | 80591000000 | 15121000000 |
| Friday, January 1, 2021 | 86645000000 | 15867000000 |
| Saturday, January 1, 2022 | 100551000000 | 15486000000 |
| Sunday, January 1, 2023 | 42907000000 | 12472000000 |
| Monday, January 1, 2024 | 115557000000 | 12827000000 |
Data in motion
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial. Over the past decade, Dr. Reddy's Laboratories Limited has consistently outpaced Novartis AG in terms of cost of revenue. From 2014 to 2023, Dr. Reddy's saw a remarkable 105% increase, peaking in 2024, while Novartis experienced a more modest 28% rise, with a notable dip in 2019. This trend highlights Dr. Reddy's aggressive expansion and operational scaling, contrasting with Novartis's steady approach. Interestingly, 2023 data shows a significant drop for Dr. Reddy's, possibly indicating strategic shifts or market challenges. Missing data for Novartis in 2024 suggests potential reporting delays or strategic changes. As the pharmaceutical landscape shifts, these insights offer a glimpse into the financial strategies of two industry giants, providing valuable lessons for stakeholders and investors alike.
Cost of Revenue Comparison: AbbVie Inc. vs Dr. Reddy's Laboratories Limited
Novartis AG vs Sanofi: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Novartis AG and Bristol-Myers Squibb Company's Expenses
Cost of Revenue Comparison: Novartis AG vs Regeneron Pharmaceuticals, Inc.
Novartis AG vs Biogen Inc.: Efficiency in Cost of Revenue Explored
Novartis AG vs Jazz Pharmaceuticals plc: Efficiency in Cost of Revenue Explored
Novartis AG vs PTC Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs Dr. Reddy's Laboratories Limited
Cost of Revenue Trends: Intra-Cellular Therapies, Inc. vs Dr. Reddy's Laboratories Limited
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Exelixis, Inc.
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Amneal Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and MiMedx Group, Inc.